Ubs Asset Management Americas Inc Moderna, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 3,597,236 shares of MRNA stock, worth $116 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,597,236
Previous 3,585,966
0.31%
Holding current value
$116 Million
Previous $149 Million
31.6%
% of portfolio
0.03%
Previous 0.04%
Shares
22 transactions
Others Institutions Holding MRNA
# of Institutions
858Shares Held
255MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$822 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$802 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$572 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$240 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...